tiprankstipranks
Trending News
More News >
Clearside Biomedical (CLSDQ)
OTHER OTC:CLSDQ
US Market

Clearside Biomedical (CLSDQ) Financial Statements

Compare
1,069 Followers

Clearside Biomedical Financial Overview

Clearside Biomedical's market cap is currently $3.93M. The company's EPS TTM is $-17.1; its P/E ratio is -0.15; Clearside Biomedical is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.66M$ 8.23M$ 1.33M$ 29.57M$ 7.89M
Gross Profit$ 1.51M$ 7.87M$ 1.12M$ 29.57M$ 7.89M
Operating Income$ -28.88M$ -24.84M$ -30.28M$ -627.00K$ -17.93M
EBITDA$ -24.35M$ -23.06M$ -29.46M$ 554.00K$ -17.70M
Net Income$ -34.35M$ -32.48M$ -32.95M$ 376.00K$ -18.21M
Balance Sheet
Cash & Short-Term Investments$ 20.02M$ 28.92M$ 48.42M$ 30.44M$ 17.29M
Total Assets$ 25.13M$ 34.02M$ 51.30M$ 42.90M$ 19.32M
Total Debt$ 52.47M$ 43.00M$ 35.26M$ 675.00K$ 1.98M
Net Debt$ 32.45M$ 14.08M$ -13.16M$ -29.76M$ -15.31M
Total Liabilities$ 63.98M$ 49.93M$ 40.70M$ 4.93M$ 10.56M
Stockholders' Equity$ -38.85M$ -15.91M$ 10.61M$ 37.98M$ 8.76M
Cash Flow
Free Cash Flow$ -25.68M$ -19.91M$ -13.61M$ -10.73M$ -13.18M
Operating Cash Flow$ -24.70M$ -18.14M$ -13.37M$ -10.73M$ -13.12M
Investing Cash Flow$ -638.00K$ -1.78M$ -246.00K$ 0.00$ -55.00K
Financing Cash Flow$ 16.44M$ 414.00K$ 31.33M$ 23.78M$ 7.87M
Currency in USD

Clearside Biomedical Earnings and Revenue History

Clearside Biomedical Debt to Assets

Clearside Biomedical Cash Flow

Clearside Biomedical Forecast EPS vs Actual EPS